What is a Benign Tumor? What is a Malignant Tumor?


A tumor is an abnormal mass of tissue that has formed a lump. It’s called benign if it grows slowly and is self-limiting; that is, if it doesn’t have the capacity to invade nearby tissues and spread beyond its original site.

A malignant, or cancerous, tumor, on the other hand, is innately dangerous because its cells can divide uncontrollably and produce virtually immortal daughter cells. Malignant tumor cells can penetrate and destroy adjacent tissue, and can metastasize, or travel through the circulation to distant parts of the body and form new tumors.

By examining biopsy samples of a tumor using a microscope and molecular tests, pathologists can classify the tumor as benign or malignant, says Keith Ligon, MD, PhD, of the Center for Molecular Oncologic Pathology at Dana-Farber/Brigham and Women’s Cancer Center. They further classify the tumor cells according to “grade,” or degree of aggressiveness. “The overall goal is to try and predict how the tumor will behave and what treatment the patient will need,” explains Ligon.

Often, benign tumors need no treatment, but they can become dangerous if they grow large enough to press on vital organs, blood vessels or nerves. In such cases they are generally removed through surgery, which also allows pathologists to confirm that they are not malignant.

Some lesions — sores or plaques of abnormal cells — and benign tumors have the potential to become malignant. These are known as “precancerous” or “dysplastic” tumors, and contain large numbers of primitive, abnormally shaped cells. Examples are precancerous polyps in the colon, growths in the cervix caused by the human papilloma virus (HPV), and dysplastic growths in the mouth and lungs. These may progress to cancer when some of the tumor cells undergo genetic changes such as mutations that give them malignant properties.

Meningiomas are a type of brain tumor that are generally benign but can become malignant. Dana-Farber researchers recently found mutations in meningiomas that are potential targets for drug therapy.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image


Latest Tweets

Dana-Farber @danafarber
RT @TheJimmyFund: Patient artwork featured in Dana-Farber & the Jimmy Fund’s 2015 Holiday Cards! https://t.co/LaxhcoXB8j https://t.co/dQACF…
Dana-Farber @danafarber
Dr. Geoffrey Oxnard offers three basic principles to live by while coping w/ lung cancer. https://t.co/1zPq5A3cYI
Dana-Farber @danafarber
Despite Difficult Stem Cell Transplant, Teen Remains Active: https://t.co/h23xggbPbN #stemcell https://t.co/r033FbE56J

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.